Pharmaceutical & Biotech News and Insights

Supply switch causing delays and cost changes for Genentech’ cancer drugs
A recent survey conducted by a hospital services company, Novation, has shown that since Genentech moved its best-selling cancer drugs to specialty distributors there have ... 
Read More


Baxter Picks HQ Location for its Biopharma Spinoff
Baxalta Incorporated, will set up shop in a 260,000 square foot building located in Bannockburn, IL, a short 6 mile trip up the road from ... 
Read More


Eisai gets an early FDA Approval
The FDA as awarded an early approval to Eisai for its new thyroid cancer drug. Lenvatinib, which will sell as Lenvima blocks the growth agent ... 
Read More


Millennium to become Takeda Oncology
Millennium, a Massachusetts based company that was purchased by Takeda in 2008, will soon become Takeda Oncology. The rebranding of the iconic biotech and an ... 
Read More


Merck to buy Cubist
As part of a plan to focus on its most promising businesses, Merck & Co. has entered an agreement to buy Cubist Pharmaceuticals. The cost ... 
Read More


Dendreon Files for Bankruptcy
Despite numerous cost cutting measures, Dendreon has filed for Chapter 11 bankruptcy protection. It wasn't too long ago that things looked promising for the company ... 
Read More


Employee Numbers at Top 10 Pharma Companies
With so many patents expiring in 2012, it was not unexpected that the ten largest big pharma companies would have fewer employees by the end ... 
Read More


Shire’s CFO is Heading to Severn Trent
Days after the news that AbbVie deal with Shire would not be moving forward, news has come that Shire's interim CFO, James Bowling, will be ... 
Read More


AstraZeneca Photo-sharing Campaign to Help Fight Breast Cancer
October is Breast cancer awareness month. Yearly recognition of the deadly disease began in 1985 when drug manufacturer AstraZeneca encouraged women to have yearly mammograms. ... 
Read More


Roche's Perjeta is helping Breast Cancer Patients Live Longer
According to newly released results at the European Society for Medical Oncology, Roche's Perjeta's is lengthening the life expectancy of patients with HER2-positive breast cancer ... 
Read More


« prev - page 1 of 3 - next »